GSK reports net profit increase of 7% in first quarter
Pharmaceutical group GlaxoSmithKline reports first-quarter profit growth driven by its medications.
Published 17sem1 sourceNotableupdated 2sem
Lire en français
≈ 16s
The fact
The increase is driven by sustained demand for its main treatments.
GSK consolidates its position in the life sciences sector.
Click the link to read an article on the topic:
Observed impact
Hausse de 7 % des bénéfices nets au T1
Renforcement de la position concurrentielle dans les sciences de la vie